PEGFILGRASTIM and DRUG DOSE OMISSION

2,104 reports of this reaction

1.4% of all PEGFILGRASTIM reports

#17 most reported adverse reaction

Overview

DRUG DOSE OMISSION is the #17 most commonly reported adverse reaction for PEGFILGRASTIM, manufactured by Amgen, Inc. There are 2,104 FDA adverse event reports linking PEGFILGRASTIM to DRUG DOSE OMISSION. This represents approximately 1.4% of all 146,341 adverse event reports for this drug.

Patients taking PEGFILGRASTIM who experience drug dose omission should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG DOSE OMISSION2,104 of 146,341 reports

DRUG DOSE OMISSION is a less commonly reported adverse event for PEGFILGRASTIM, but still significant enough to appear in the safety profile.

Other Side Effects of PEGFILGRASTIM

In addition to drug dose omission, the following adverse reactions have been reported for PEGFILGRASTIM:

DEVICE ADHESION ISSUE — 11,436 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS — 10,236 reports
UNINTENTIONAL MEDICAL DEVICE REMOVAL — 8,931 reports
DEVICE MALFUNCTION — 6,834 reports
DEVICE USE ERROR — 6,023 reports
DEVICE ISSUE — 5,094 reports
ACCIDENTAL EXPOSURE TO PRODUCT — 4,983 reports
OFF LABEL USE — 3,759 reports
FEBRILE NEUTROPENIA — 3,697 reports
DEVICE OCCLUSION — 3,272 reports

Other Drugs Associated with DRUG DOSE OMISSION

The following drugs have also been linked to drug dose omission in FDA adverse event reports:

ACLIDINIUM BROMIDE BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE CARBAMIDE PEROXIDE 6.5%CINACALCET HYDROCHLORIDE DALFAMPRIDINE ESOMEPRAZOLE MAGNESIUM EVOLOCUMAB FLUTICASONE PROPIONATE AND SALMETEROL INSULIN LISPRO IVACAFTOR LEDIPASVIR AND SOFOSBUVIR METHYLPHENIDATE MOMETASONE FUROATE MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE PALIPERIDONE PALMITATE PATIROMER QUETIAPINE TERIPARATIDE TETRABENAZINE UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Frequently Asked Questions

Does PEGFILGRASTIM cause DRUG DOSE OMISSION?

DRUG DOSE OMISSION has been reported as an adverse event in 2,104 FDA reports for PEGFILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG DOSE OMISSION with PEGFILGRASTIM?

DRUG DOSE OMISSION accounts for approximately 1.4% of all adverse event reports for PEGFILGRASTIM, making it a notable side effect.

What should I do if I experience DRUG DOSE OMISSION while taking PEGFILGRASTIM?

If you experience drug dose omission while taking PEGFILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

PEGFILGRASTIM Full Profile All Drugs Causing DRUG DOSE OMISSION Amgen, Inc Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.